Does potassium help with sleep?

We cannot say yet. No systematic review has pooled trials of potassium for sleep. The randomized evidence is two small trials: a 1991 crossover in young men kept on a low-potassium diet, and a 2024 single-blind trial in 290 people with diabetes and insomnia. Both found some improvement. Neither tells you what a potassium supplement would do for an ordinary bad night.

Unsettled. The two trials point the same way and are too small and too unusual to build on. One studied men whose diets had been stripped of potassium, and the other people with diabetes, mixing potassium with magnesium. Surveys link less potassium with worse sleep, and surveys cannot show cause.

What the trials found

The 1991 crossover

Healthy young men on a low-potassium diet took 96 mEq of potassium chloride a day or placebo for a week each, double-blind. Potassium raised sleep efficiency measured by a wrist monitor (p less than 0.05), because they spent less time awake after first falling asleep. Bedtime shifted later. The abstract does not say how many men took part, the sleep was measured by actigraphy rather than in a sleep laboratory, and nobody has repeated the trial.

The 2024 trial in diabetes

In 320 people with diabetes and insomnia, of whom 290 finished, two months of magnesium, potassium or both lowered insomnia severity compared with placebo, by improving sleep duration. Only the participants were blinded. The abstract gives neither the size of the change nor the potassium dose, so we cannot tell you how much it helped or at what amount.

The broad review that left potassium out

A 2025 meta-analysis of 28 randomized trials of dietary supplements for sleep named tryptophan, vitamin D, omega-3, zinc and antioxidants as helpful. Potassium was not among them. The abstract does not say whether any potassium trial was included, so this is a gap in the evidence and not a negative result.

Survey data

Extra minutes to fall asleep, by sodium to potassium ratio

A cross-sectional study of 4825 smartphone app users, with sleep measured by the phone. The lines are 95% confidence intervals. It measures the ratio of sodium to potassium, not potassium alone, and it cannot show cause. Source: card ev-ksleep-05 below.

Three cross-sectional studies link potassium with sleep. In 4568 users of a Japanese food-logging app, people with worse insomnia scores ate less potassium a day, and potassium at dinner showed the strongest link. Dinner potassium may simply mark a better diet. In 4825 users of two smartphone apps, a higher ratio of sodium to potassium went with shorter sleep, by 0.11 hours (95% CI 0.02 to 0.20) and 0.19 hours (95% CI 0.10 to 0.28) in the top two quarters. In 6730 US adults from NHANES, potassium was one of many nutrients that statistically explained part of the link between food insecurity and irregular sleep. None of these can show that potassium causes better sleep.

Who should be careful

In the trials that tested it, extra potassium was safe for people whose kidneys clear it normally. Across 22 randomized trials in 1606 adults, more potassium did not harm kidney function, blood lipids or catecholamines. In 23 placebo-controlled trials in 1213 people with high blood pressure, potassium supplements caused no important adverse effects and lowered systolic pressure by 4.25 mm Hg. Neither review shows that this holds for people with kidney disease.

Not for everyone. Potassium supplements and potassium salt substitutes are a risk if you take ACE inhibitors or angiotensin receptor blockers, or potassium-sparing diuretics such as amiloride and spironolactone. All of these reduce the potassium lost in urine and can cause hyperkalemia, a dangerously high blood potassium. The same goes for kidney disease. Talk to whoever prescribes your medicine before taking potassium for sleep.

Salt substitutes add potassium too. A Cochrane review of 26 trials found they probably raise blood potassium slightly, by 0.12 mmol/L (95% CI 0.07 to 0.18), on moderate-certainty evidence. Every one of those trials excluded people for whom potassium might be harmful, so the review cannot say whether the substitutes are safe for them. The NIH adds that very high amounts of potassium supplements or salt substitutes can exceed what the kidneys can clear and cause acute hyperkalemia even in healthy people.

What expert bodies say

We found no expert body that makes any statement about potassium for sleep. The NIH Office of Dietary Supplements fact sheet we used speaks only to safety, and its warnings are the ones above on high doses, blood pressure drugs and potassium-sparing diuretics.

How we searched

Searched: a local copy of the PubMed baseline, queried on 7 October 2026 for dietary potassium, potassium supplements, potassium chloride and potassium citrate with sleep, insomnia, sleep apnoea and restless legs (130 hits, top 60 screened). Most hits were drugs sold as potassium salts or studies of potassium channels. We also searched reviews of minerals and sleep (40 screened), reviews of potassium safety (13 hits), the NIH potassium fact sheet, ClinicalTrials.gov and a web search for newer work. All cited papers were checked against Retraction Watch.

Included: 9 papers and the NIH fact sheet: one meta-analysis of supplements for sleep, two randomized trials, three cross-sectional studies and three meta-analyses of potassium safety.

Excluded: oxybate salts for narcolepsy, diclofenac potassium and clorazepate, which are drugs and not dietary potassium. Studies of potassium channels. A salt substitution meta-analysis covered by the Cochrane review, and an observational study of potassium in kidney disease.

What we read: abstracts, with each quotation checked against the abstract text, and three passages of the NIH fact sheet.

What we could not get: the full text of the 1991 trial, which has no DOI and no free version, so the number of participants is unknown. The full text of the 2024 diabetes trial, which would give the potassium dose and the size of the effect.

What would change this answer

A placebo-controlled trial of potassium alone, at a stated dose, in adults with poor sleep on an ordinary diet, with sleep measured in a laboratory. No such trial exists.
A systematic review that pools potassium trials for sleep. None has been done, and two trials are not yet enough to pool.
The size of the effect in the 2024 diabetes trial, and whether potassium alone did as well as potassium with magnesium.
Our trial registry search found no active trial of potassium for sleep.

The rest of the nutrient, in one place. Potassium: the mineral most people under-eat, and the one some people must limit → What it does, how much you need, who runs short, and what too much does, with the evidence level shown on every line.

The full guide

Potassium: the mineral most people under-eat, and the one some people must limit

The same question for other foods (sleep)

Sources

ev-ksleep-01 · Meta-analysis or systematic review · systematic review and meta-analysis of RCTs · n = 28 RCTs
CONCLUSIONS: These findings suggest that tryptophan, vitamin D, omega-3, zinc, and antioxidants may enhance sleep quality by decreasing SL, and WASO increases SE and extends TST, respectively.
Who: People with sleep disorders and healthy individuals in 28 RCTs
Effect: Pooled supplements: PSQI MD -0.70 (95% CI -1.37 to -0.03); WASO SMD -0.30 (-0.48 to -0.12); potassium not named among effective nutrients
Certainty: Potassium does not appear in the conclusion; it is not clear from the abstract whether potassium RCTs were among the 28. The answer to H1 is a gap, not a negative result.
Nutrients, 2025 · checked 2026-10-07 · we read the abstract
ev-ksleep-02 · Randomized controlled trial(s) · randomized double-blind placebo-controlled crossover trial, 1 week per arm · n = —
Potassium significantly increased actigraphic Sleep Efficiency (p less than 0.05) due to a reduction in actigraphic Wake after Sleep Onset (WASO) (p less than 0.05).
Who: Normal young males on a low-potassium diet
Effect: Actigraphic sleep efficiency up (p < 0.05) via less wake after sleep onset (p < 0.05); bedtime delayed; no change in sleep phase
Certainty: The number of participants is not given in the abstract; men only on an artificially potassium-poor diet; actigraphy, not polysomnography. Dose 96 mEq potassium per day (about 3.75 g potassium, card arithmetic).
Sleep, 1991 · checked 2026-10-07 · we read the abstract
ev-ksleep-03 · Randomized controlled trial(s) · single-blind randomized controlled trial, 4 arms, 2 months · n = 290
In addition, supplementation significantly decreased the severity of insomnia among patients with diabetes by improving sleep duration.
Who: Patients with diabetes and insomnia; 320 randomized, 290 completed
Effect: Significant association between treatment group and post-trial Insomnia Severity Index (p = 0.0001); size of change not given in the abstract
Certainty: Single-blind only; the effect size and potassium dose are not in the abstract; only people with diabetes.
Front Endocrinol (Lausanne), 2024 · checked 2026-10-07 · we read the abstract
ev-ksleep-04 · Observational data · cross-sectional study · n = 4568
RESULTS: Multiple regression analyses revealed that individuals with higher AIS scores had lower daily potassium intake; potassium at dinner was especially crucial.
Who: Users of a Japanese food-logging app, age 43.5 ± 11.2 years
Effect: Higher Athens Insomnia Scale scores with lower daily potassium intake; dinner potassium most strongly associated
Certainty: Cross-sectional; self-report; potassium at dinner may be a marker of diet quality.
Nutrients, 2024 · checked 2026-10-07 · we read the abstract
ev-ksleep-05 · Observational data · cross-sectional study with objective app-measured sleep · n = 4825
A greater sodium-to-potassium ratio was associated with shorter TST in the third (-0.11, 95% CI -0.20 to -0.02 h) and fourth (-0.19, 95% CI -0.28 to -0.10 h) quartiles; longer SL in the second (+1.03, 95% CI 0.08-1.98 min) and fourth (+1.50, 95% CI 0.53-2.47 min) quartiles; and longer %WASO in the fourth quartile (0.71%, 95% CI 0.15%-1.28%).
Who: Users of Pokemon Sleep and Asken smartphone apps for at least 7 days
Effect: Total sleep time -0.11 h (95% CI -0.20 to -0.02) and -0.19 h (-0.28 to -0.10) in the 3rd and 4th Na:K quartiles
Certainty: Cross-sectional; sleep with a smartphone; the Na:K ratio, not potassium alone.
J Med Internet Res, 2025 · checked 2026-10-07 · we read the abstract
ev-ksleep-06 · Observational data · cross-sectional mediation analysis · n = 6730
Dietary intake of fiber; vitamins A, B1, B2, C, E, and K; β-carotene; zinc; copper; and potassium and serum concentrations of palmitoleic acid had significant indirect effects on this association.
Who: US adults, NHANES 2011-2014, with actigraphy
Effect: Potassium intake had a significant indirect (mediating) effect on the food insecurity and sleep regularity association
Certainty: A mediation analysis in a cross-section does not establish causality; potassium is one of many nutrients.
Nutrients, 2025 · checked 2026-10-07 · we read the abstract
ev-ksleep-07 · Meta-analysis or systematic review · systematic review and meta-analysis of RCTs and cohorts · n = 1606
Increased potassium intake had no significant adverse effect on renal function, blood lipids, or catecholamine concentrations in adults.
Who: Adults in 22 RCTs
Effect: No significant adverse effect on renal function, blood lipids or catecholamine concentrations; systolic BP -3.49 mm Hg (1.82 to 5.15)
Certainty: High-quality evidence for blood pressure; safety only in people without impaired renal potassium excretion.
BMJ, 2013 · checked 2026-10-07 · we read the abstract
ev-ksleep-08 · Meta-analysis or systematic review · meta-analysis of randomized placebo-controlled trials · n = 1213
CONCLUSIONS: Our findings indicated that potassium supplementation is a safe medication with no important adverse effects that has a modest but significant impact BP and may be recommended as an adjuvant antihypertensive agent for patients with essential hypertension.
Who: Patients with primary hypertension in RCTs of at least 4 weeks
Effect: SBP MD -4.25 mmHg (95% CI -5.96 to -2.53); DBP MD -2.53 mmHg (-4.05 to -1.02); no important adverse effects
Certainty: Only people with essential hypertension; the safety conclusion does not transfer to CKD or ACE inhibitor use.
PLoS One, 2017 · checked 2026-10-07 · we read the abstract
ev-ksleep-09 · Meta-analysis or systematic review · Cochrane systematic review and meta-analysis of RCTs · n = 784
However, LSSS also probably increase blood potassium slightly in adults.
Who: Adults in RCTs of low-sodium salt substitutes; blood potassium from 6 RCTs
Effect: Blood potassium MD +0.12 mmol/L (95% CI 0.07 to 0.18), moderate certainty; hyperkalemia little to no difference in trials that excluded at-risk people
Certainty: All 26 RCTs excluded people for whom potassium is potentially harmful; a conclusion on safety for them is impossible.
Cochrane Database Syst Rev, 2022 · checked 2026-10-07 · we read the abstract
ev-ksleep-10 · Position of an expert body · agency fact sheet · n = —
However, very high amounts of potassium supplements or salt substitutes that contain potassium could exceed the kidney’s capacity to excrete potassium, causing acute hyperkalemia even in healthy individuals.
Who: Healthy individuals taking very high amounts of potassium supplements or salt substitutes
Effect: Risk of acute hyperkalemia at very high supplemental doses
Certainty: Authority position without its own analysis; the quote does not give the "very high" threshold.
NIH Office of Dietary Supplements, Potassium Fact Sheet for Health Professionals · checked 2026-10-07 · we read the section
ev-ksleep-11 · Position of an expert body · agency fact sheet · n = —
These medications reduce urinary potassium excretion, which can lead to hyperkalemia.
Who: People taking ACE inhibitors or angiotensin receptor blockers
Effect: Reduced urinary potassium excretion; risk of hyperkalemia; monitoring advised
Certainty: Drug interaction; together with potassium-sparing diuretics (amiloride, spironolactone) it is the main reason not to take potassium "for sleep" without a doctor.
NIH Office of Dietary Supplements, Potassium Fact Sheet for Health Professionals · checked 2026-10-07 · we read the section
ev-ksleep-12 · Position of an expert body · agency fact sheet · n = —
Potassium-sparing diuretics, such as amiloride (Midamor) and spironolactone (Aldactone), reduce the excretion of potassium in the urine and can cause hyperkalemia [77,78].
Who: People taking potassium-sparing diuretics
Effect: Reduced urinary potassium excretion; hyperkalemia risk
Certainty: Authority position.
NIH Office of Dietary Supplements, Potassium Fact Sheet for Health Professionals · checked 2026-10-07 · we read the section

How this page was made. Evidence was extracted from primary sources into cards, every number was re-checked against the source, and the text was written from those cards. Bioma Learn has no human medical reviewer at this time, and we say so rather than invent one. Methodology. This is information, not medical advice.